KRB-456 Suppresses the Levels of KRAS Bound to GTP, Inhibits the Binding of KRAS to RAF1, and Deceases P-MEK and P-ERK Levels in Human Pancreatic Cancer Cells. Here, KRAS is linked to pancreatic neoplasm.